000 | 01726 a2200505 4500 | ||
---|---|---|---|
005 | 20250516214859.0 | ||
264 | 0 | _c20140905 | |
008 | 201409s 0 0 eng d | ||
022 | _a1479-6805 | ||
024 | 7 |
_a10.1530/JOE-14-0161 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOgata, Hidetada | |
245 | 0 | 0 |
_aKATP channel as well as SGLT1 participates in GIP secretion in the diabetic state. _h[electronic resource] |
260 |
_bThe Journal of endocrinology _cAug 2014 |
||
300 |
_a191-200 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xphysiopathology |
650 | 0 | 4 |
_aDiazoxide _xpharmacology |
650 | 0 | 4 |
_aGastric Inhibitory Polypeptide _xmetabolism |
650 | 0 | 4 |
_aGlucose _xpharmacology |
650 | 0 | 4 |
_aKATP Channels _xphysiology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPhlorhizin _xpharmacology |
650 | 0 | 4 |
_aPotassium Channels, Inwardly Rectifying _xdeficiency |
650 | 0 | 4 |
_aSodium-Glucose Transporter 1 _xphysiology |
650 | 0 | 4 |
_aSulfonylurea Compounds _xpharmacology |
700 | 1 | _aSeino, Yusuke | |
700 | 1 | _aHarada, Norio | |
700 | 1 | _aIida, Atsushi | |
700 | 1 | _aSuzuki, Kazuyo | |
700 | 1 | _aIzumoto, Takako | |
700 | 1 | _aIshikawa, Kota | |
700 | 1 | _aUenishi, Eita | |
700 | 1 | _aOzaki, Nobuaki | |
700 | 1 | _aHayashi, Yoshitaka | |
700 | 1 | _aMiki, Takashi | |
700 | 1 | _aInagaki, Nobuya | |
700 | 1 | _aTsunekawa, Shin | |
700 | 1 | _aHamada, Yoji | |
700 | 1 | _aSeino, Susumu | |
700 | 1 | _aOiso, Yutaka | |
773 | 0 |
_tThe Journal of endocrinology _gvol. 222 _gno. 2 _gp. 191-200 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1530/JOE-14-0161 _zAvailable from publisher's website |
999 |
_c23882645 _d23882645 |